Nomura Maintains Buy on Solid Biosciences, Raises Price Target to $10

Nomura maintains Solid Biosciences (NASDAQ:SLDB) with a Buy and raises the price target from $6 to $10.

Benzinga · 12/19/2019 13:34

Nomura maintains Solid Biosciences (NASDAQ:SLDB) with a Buy and raises the price target from $6 to $10.